Tools
Tools
Tamarozzi, Francesca, Tendongfor, Nicholas, Enyong, Peter, Esum, Mathias, Faragher, Brian, Wanji, Samuel and Taylor, Mark 
ORCID: https://orcid.org/0000-0003-3396-9275
(2012)
'Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis'. Parasites & Vectors, Vol 5, e53.
|
Text
Para_Vect_5_53.pdf - Published Version Available under License Creative Commons Attribution. Download (279kB) | Preview |
Abstract
Background
Anti-Wolbachia treatment with doxycycline is effective in sterilising and killing adult Onchocerca volvulus nematodes, proving superior to ivermectin and of great potential as an alternative approach for the treatment and control of onchocerciasis, particularly in areas of Loa loa co-endemicity. Nevertheless, the length of the required treatment poses potential logistical problems and risk of poor compliance, raising a barrier to the use of doxycycline in Mass Drug Administration (MDA) strategies. In 2007 and 2008 a feasibility trial of community-directed treatment with doxycycline was carried out in two health districts in Cameroon, co-endemic for O. volvulus and L. loa. With 17,519 eligible subjects, the therapeutic coverage was 73.8% with 97.5% compliance, encouraging the feasibility of using doxycycline community-directed delivery in restricted populations of this size. The current study evaluated the effectiveness of this community-directed delivery of doxycycline four years after delivery.
Findings
Infection with O. volvulus was evaluated by skin biopsy and nodule palpation. Of the 507 subjects recruited, 375 had completed the treatment with doxycycline followed by one or two rounds of annual ivermectin MDA and 132 received one or two rounds of annual ivermectin MDA alone. Statistically significant lower microfilarial prevalence (17.0% [doxycycline plus ivermectin group], 27.0% [ivermectin only group], p = 0.014) and load (p = 0.012) were found in people that had received doxycycline followed by ivermectin compared to those who received ivermectin only.
Conclusions
This study demonstrates the long-term effectiveness of doxycycline treatment delivered with a community-directed strategy even when evaluated four years after delivery in an area of ongoing transmission. This finding shows that a multi-week course of treatment is not a barrier to community-delivery of MDA in restricted populations of this size and supports its implementation to compliment existing control strategies for onchocerciasis, where needed.
| Item Type: | Article |
|---|---|
| Additional Information: | The electronic version of this article is the complete one and can be found online at: http://www.parasitesandvectors.com/content/5/1/53 |
| Subjects: | QV Pharmacology > Anti-Bacterial Agents. Tissue Extracts > QV 360 Tetracyclines WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases WC Communicable Diseases > Tropical and Parasitic Diseases > WC 885 Onchocerciasis |
| Faculty: Department: | Groups (2002 - 2012) > Clinical Group Groups (2002 - 2012) > Molecular & Biochemical Parasitology Group |
| Digital Object Identifer (DOI): | https://doi.org/10.1186/1756-3305-5-53 |
| Depositing User: | Users 379 not found. |
| Date Deposited: | 10 Sep 2012 09:53 |
| Last Modified: | 16 Sep 2019 09:01 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/3012 |
Statistics
Actions (login required)
 |
Edit Item |